NovAccess Global Inc. (XSNX)
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Sector: Biotechnology
Industry: Biotechnology
NovAccess Global Inc.
OTC:XSNXHealthcare · Biotechnology
$0.0001
CLOSED · Nov 11Prev close$0.0001Close$0.0001
Mkt Cap$6K
EV-
Float26.32M
O/S61.65M
VOL200 sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
MCap$6KFloat26.32MO/S61.65M
Dilution
| Form | Description | Links | |
|---|---|---|---|